Circulating Clusterin Levels and Cancer Risk: A Systematic Review and Meta-Analysis.

Ali Beheshti NamdarMona KabiriHoman Mosanan MozaffariElham AminifarHassan Mehrdad-Majd

Published in: Cancer control : journal of the Moffitt Cancer Center (2022)

The present meta-analysis indicates a significant association of CLU levels with the risk of digestive system cancers such as hepatocellular carcinoma and colorectal cancer. Therefore, CLU can be monitored as a novel molecular biomarker for the prognosis and diagnosis of various types of cancers particularly in the digestive system.

Keyphrases

systematic review
meta analyses
randomized controlled trial
young adults